Nursing Elites

1. The nurse teaches an adolescent male client how to use a metered dose inhaler. What instruction should the nurse provide?

• A. Secure the mouthpiece under the tongue.
• B. Press down on the device after breathing in fully.
• C. Move the device one to two inches away from the mouth.
• D. Breathe out slowly and deeply while compressing the device.

Correct answer: C

Rationale: The correct instruction for using a metered dose inhaler is to move the device one to two inches away from the mouth. This distance helps ensure effective delivery of the medication directly to the airways. Choice A is incorrect as the mouthpiece should be placed between the lips, not under the tongue. Choice B is incorrect because the device should be pressed down before breathing in, not after. Choice D is wrong because the patient should breathe out fully before using the inhaler, not while compressing the device.

2. A client with cirrhosis is admitted with jaundice and ascites. Which clinical finding is most concerning?

• A. Increased abdominal girth
• B. Confusion and altered mental status
• C. Yellowing of the skin
• D. Peripheral edema

Correct answer: B

Rationale: Confusion and altered mental status are concerning in a client with cirrhosis as they may indicate hepatic encephalopathy, a serious complication that requires immediate intervention. Increased abdominal girth can be seen in ascites, yellowing of the skin is due to jaundice, and peripheral edema is associated with fluid retention in cirrhosis, but confusion and altered mental status are more closely linked to hepatic encephalopathy, which can progress rapidly and needs urgent attention.

3. The nurse is caring for a client with a history of atrial fibrillation who is prescribed warfarin (Coumadin). Which laboratory value should the nurse monitor closely?

• A. Prothrombin time (PT)
• B. Hemoglobin level
• C. International Normalized Ratio (INR)
• D. Serum sodium level

Correct answer: C

Rationale: The INR should be closely monitored in a client prescribed warfarin (Coumadin) to assess the effectiveness and safety of anticoagulation therapy. Monitoring the INR helps determine if the client's blood is clotting appropriately. While prothrombin time (PT) is related to warfarin therapy, the INR is a more precise measure. Hemoglobin level and serum sodium level are not directly related to monitoring warfarin therapy.

4. A female client receives a prescription for alendronate sodium (Fosamax) to treat her newly diagnosed osteoporosis. What instruction should the nurse include in the client's teaching plan?

• A. Take on an empty stomach with a full glass of water.
• B. Take with food to avoid stomach upset.
• C. Take before bedtime with a light snack.
• D. Take with milk to enhance absorption.

Correct answer: A

Rationale: The correct answer is to take alendronate on an empty stomach with a full glass of water. This instruction is essential to ensure proper absorption and prevent esophageal irritation. Taking alendronate with food, before bedtime with a light snack, or with milk can interfere with its absorption and effectiveness, leading to potential side effects or reduced therapeutic benefits.

5. A client with a history of atrial fibrillation is prescribed warfarin (Coumadin). Which laboratory value should the nurse monitor closely?

• A. Prothrombin time (PT)
• B. Hemoglobin level
• C. International Normalized Ratio (INR)
• D. Serum sodium level

Correct answer: C

Rationale: The correct answer is C, International Normalized Ratio (INR). The INR should be closely monitored in a client prescribed warfarin (Coumadin) to assess the effectiveness and safety of anticoagulation therapy. Monitoring the INR helps ensure that the client is within the therapeutic range for anticoagulation, reducing the risk of bleeding or clotting complications. Prothrombin time (A) is used to calculate the INR and monitor the effectiveness of warfarin therapy. Hemoglobin level (B) is important but not the primary lab value to monitor when a client is on warfarin. Serum sodium level (D) is not directly related to monitoring warfarin therapy.

Similar Questions